Maravai LifeSciences Holdings, Inc.
MRVI
$2.45
$0.062.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -304.44% | -147.93% | 75.33% | -1,432.62% | -49.66% |
| Total Depreciation and Amortization | 5.77% | 8.41% | 11.91% | 7.20% | 23.30% |
| Total Amortization of Deferred Charges | -47.45% | -37.70% | -11.44% | 2.17% | 2.06% |
| Total Other Non-Cash Items | 115.32% | -26.97% | -93.51% | 5,250.84% | 207.82% |
| Change in Net Operating Assets | -81.49% | 151.59% | -520.93% | -32.35% | -66.74% |
| Cash from Operations | -158.88% | -10.90% | -287.91% | -7.27% | -9.17% |
| Capital Expenditure | 69.92% | 7.59% | 65.18% | 45.72% | 61.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -48.35% | -76.44% | -219.87% | 325.09% |
| Cash from Investing | 47.65% | -444.98% | 61.78% | 42.27% | 74.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.59% | -2.52% | -15,245.74% | -2.43% | -5.75% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -230.22% | -71.51% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -42.18% | -360.31% | 20.10% | 104.19% |
| Cash from Financing | -772.81% | -775.00% | -50,352.98% | 3.32% | 100.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -231.93% | -181.41% | -5,408.46% | 973.20% | 123.87% |